Skip to main content
2024 CRT Conference Main banner
Back

CRT 2024

Late-Breaking

Late-Breaking Clinical Trials - Structural / LAA [Non-CME]

Cost-Effectiveness of Transcatheter Aortic Valve Replacement for Low-Risk Patients – Updated Results from the Evolut Low Risk Trial

Monday, March 11, 2024
11:55 AM – 12:05 PM ET

    Speaker(s)

  • David J. Cohen, MD, FSCAI

    Director of Clinical and Outcomes Research
    Cardiovascular Research Foundation
    New York, New York, United States

    No relationships to disclose